...
首页> 外文期刊>Journal of land use science >Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose
【24h】

Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose

机译:用重组rhc23接种羊羔对Haemonchus曲率的疫苗。 佐剂和抗原剂量的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Haemonchus contortus is the most pathogenic gastrointestinal helminth of small ruminants. Natural or experimental repeated infections and several native antigens confer a partially protective immune response but vaccination with subunit antigens has been elusive. Promising results have been obtained with a recombinant form of a somatic antigen (rHc23). In this paper we present the results obtained in vaccination trials in lambs using two dosages of rHc23 and standard adjuvants. Six-months old Manchego females lambs were vaccinated with rHc23 (50 or 200 mu g/dose) adjuvanted with 1mL aluminum hydroxide on days -42, -28 and -14 or with 200 mu g/dose rHc23 and 5 mg Quil A on days -49, -28 and -7. Control lambs were kept receiving only the adjuvants the same days or no treatment. Moreover one group did not receive any treatment or infection. On day 0 vaccinated lambs, untreated animals and those receiving the adjuvant were infected per os with a monospecific single infection of 4000 L3 of H. contortus. Infection was kept for 58 days and follow-up included the determination of serum specific antibody response (ELISA, WB), hematological parameters (eosinophil counts, hematocrit) and fecal egg counts (epg). Absence of hematocrit alterations, reduction of helminth's eggs output and abomasal parasite burden at the end of the experiment were the efficacy criteria of vaccination with the recombinant. Immunization with both adjuvants and antigen dosages elicited strong antibody responses particularly with Quil A. Vaccinated groups showed significant reduction of fecal egg excretion and abomasal helminth burdens. Highest protection of lambs against challenge was achieved with aluminum hydroxide and 200 mu g/dose rHc23 with a reduction of over 70% of the abomasal burden and over 80% of fecal egg output. Results suggest that rHc23 could be a valuable recombinant candidate for vaccination against haemonchosis. No clear relationship was found between antibody levels and protection this pointing towards involvement of both humoral and cellular components in the protective response elicited by rHc23.
机译:haemonchus intortus是小反刍动物的最致病性胃肠蠕虫。天然或实验性重复感染和几种天然抗原赋予部分保护性免疫应答,但与亚基抗原的疫苗接种已经难以捉摸。已经用重组形式的体细胞抗原(RHC23)获得了有希望的结果。在本文中,我们介绍了使用两种rHC23和标准佐剂的羊羔疫苗接种试验中获得的结果。六个月的Manchego女性羊羔用rhC23(50或200μg/剂量)接种用1ml氢氧化铝氢氧化铝溶液 - 42,-28和-14或200μmg/剂量rhc23和5mg quil a -49,-28和-7。对照羔羊保持同一天或未治疗的佐剂。此外,一组没有接受任何治疗或感染。在第0天疫苗接种的羊羔,未经处理的动物和接受佐剂的那些,每种OS感染具有4000L3的单特异性的单次感染H. pultortus。感染58天,随访包括测定血清特异性抗体反应(ELISA,WB),血液学参数(嗜酸性粒细胞计数,血细胞比容)和粪便蛋计数(EPG)。没有血细胞比容的改变,蠕虫的卵产出和脱毛寄生虫在实验结束时的负担是疫苗接种的功效标准。用佐剂和抗原剂量免疫引发强烈的抗体应答,特别是与Quil A.疫苗接种的基团显示出粪便蛋排泄和脱毛蠕虫负担的显着降低。用氢氧化铝和200μg/剂量rhC23实现了最高保护抗攻击性攻击,减少了超过70%的阿巴马酸盐负担和超过80%的粪便蛋输出。结果表明RHC23可以是抗毛虫疫苗的有价值的重组候选者。在抗体水平和保护之间未发现明确的关系,这指向rHC23引发的保护响应中的体液和细胞组分涉及体液和细胞组分之间的累积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号